
Targeted therapies, CDK4/6 inhibitors, and precision medicine are improving outcomes for patients with high-risk and metastatic disease.
Targeted therapies, CDK4/6 inhibitors, and precision medicine are improving outcomes for patients with high-risk and metastatic disease.
Rising cancer rates and costs pose challenges in global oncology markets amid AI and targeted therapy breakthroughs.
Experts from Moffitt Cancer Center discuss the benefit of multidisciplinary teams in lung cancer care.
The 2024 NCODA International Fall Summit took place in Orlando, Florida, from October 23 to October 25.
Liz Vogel, CPhT-Adv, CSPT, discusses the procedures and best practices for safe compounding of hazardous and non-hazardous drugs.
Stephanie White, PharmD, CSP, is presenting at the NCODA Fall Summit in Orlando, Florida.
Ginger Blackmon, PharmD, will discuss enhancing patient cancer care through implementation of medically integrated oncology team and NCODA’s PQI resources.
Pharmacy Times will be at the NCODA Fall Summit in Orlando from October 23 to October 25, 2024.
Pharmacists address aspects of patient care that are unique to the focus of the pharmacist, such as financial toxicity and data collection for components of social determinants of health (SDOH).